Medicare Advantage insurers ramped up tech use to deny claims, Senate investigation shows

UnitedHealth, Humana, and CVS denied a quarter of all post-acute coverage requests for MA patients

October 17, 2024 Check out STAT+

Sponsored By

David Goldman/AP STAT+ | Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows The Senate report extensively cites STAT's investigation of the use of algorithms and artificial intelligence within Medicare Advantage plans. By Bob Herman and Casey Ross STAT+ | Former UnitedHealth doctors detail what changed at their clinics after takeovers The doctors said they lost control over their schedules, were told to prioritize coding patients' illnesses, and felt like widgets. By Bob Herman Atul Gawande on the problem that's even 'bigger' than health care Atul Gawande, surgeon and author of "Being Mortal," spoke at the STAT Summit about longevity, public health, and his time at Haven. By Timmy Broderick Alex Hogan/STAT STAT+ | How invisible medical groups are powering telehealth's GLP-1 'gold rush' Telehealth sites prescribing GLP-1s get off the ground in a matter of days by "renting" the services of these medical groups. By Katie Palmer STAT+ | Alnylam's CEO on welcoming competition, turning a profit, and a 'spine-tingling moment' Yvonne Greenstreet predicts vutrisiran will become multibillion-dollar product for ATTR-cardiomyopathy, despite increasing competition. By Elizabeth Cooney Biotech veteran Tony Coles on partisan politics and fulfilling a promise to his co-founder Coles has arguably been just as active pushing the drug industry and other business leaders towards difficult conversations as he has been on making deals. By Allison DeAngelis Adobe STAT+ | For this cancer-focused digital health startup, an FDA rejection meant the end of the road Blue Note's failure to clear the FDA hurdle offers a rare window into the regulatory challenges faced by digital therapeutics companies. By Mario Aguilar

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser